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ABSTRACT
Previous studies revealed pharmacological differences be-
tween human and guinea pig histamine H2 receptors (H2Rs)
with respect to the interaction with guanidine-type agonists.
Because H2R species variants are structurally very similar,
comparative studies are suited to relate different properties of
H2R species isoforms to few molecular determinants. There-
fore, we systematically compared H2Rs of human (h), guinea
pig (gp), rat (r), and canine (c). Fusion proteins of hH2R, gpH2R,
rH2R, and cH2R, respectively, and the short splice variant of
Gs, GsS, were expressed in Sf9 insect cells. In the membrane
steady-state GTPase activity assay, cH2R-GsS but neither
gpH2R-GsS nor rH2R-GsS showed the hallmarks of increased
constitutive activity compared with hH2R-GsS, i.e., increased
efficacies of partial agonists, increased potencies of agonists
with the extent of potency increase being correlated with the
corresponding efficacies at hH2R-GsS, increased inverse ag-
onist efficacies, and decreased potencies of antagonists. Fur-
thermore, in membranes expressing nonfused H2Rs without or
together with mammalian GsS or H2R-Gs fusion proteins, the
highest basal and GTP-dependent increases in adenylyl cy-
clase activity were observed for cH2R. An example of ligand
selectivity is given by metiamide, acting as an inverse agonist at
hH2R-GsS, gpH2R-GsS, and rH2R-GsS in the GTPase assay
in contrast to being a weak partial agonist with decreased
potency at cH2R-GsS. In conclusion, the cH2R exhibits in-
creased constitutive activity compared with hH2R, gpH2R, and
rH2R, and there is evidence for ligand-specific conformations in
H2R species isoforms.
The histamine H2 receptor (H2R) species isoforms of canine
(Gantz et al., 1991b), human (Gantz et al., 1991a), rat (Ruat
et al., 1991), and guinea pig (Traiffort et al., 1995) were
cloned. The four H2R species isoforms are closely related to
each other, as is reflected by an overall amino acid sequence
identity of more than 80%. The highest conservation exists
within the seven -helical transmembrane (TM) domains
(sequence identity of more than 90%), whereas the N-termi-
nal domain together with the extracellular end of TM1 and
the C terminus are the least conserved regions (Fig. 1).
Despite this high degree of structural similarity, N-[3-(1H-
imidazol-4-yl)propyl]guanidines such as compounds 8 to 10
(Fig. 2) differentially activate guinea pig (gpH2R) and human
(hH2R) H2 receptors. In a membrane steady-state GTPase
activity assay using fusion proteins of H2R and the short
splice variant of Gs, GsS, such H2R-selective agonists are
considerably more potent and efficacious at gpH2R-GsS than
at hH2R-GsS (Kelley et al., 2001). By contrast, the small H2R
agonists histamine (1, HA), dimaprit (2, DIM), amthamine
(3, AMT), and betahistine (4, BET) are unselective between
these species. Recently, a novel class of NG-acylated imida-
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zolylpropylguanidines as represented by compounds 11 to 16
was developed (Ghorai, 2005; Xie et al., 2006a). Generally, by
introduction of a carbonyl group adjacent to the guanidine
moiety, the species selectivity of the agonists is preserved
(Xie et al., 2006a). Comparison of the corresponding agonist
efficacies in the GTPase assay and at stabilizing the high-
affinity ternary complex of the H2R with nucleotide-free Gs
indicate that N-[3-(1H-imidazol-4-yl)propyl]guanidines and
their NG-acylated analogs stabilize different ligand-specific
active conformations of hH2R and gpH2R (Kelley et al., 2001;
Xie et al., 2006a). However, it is not known whether these
differences also apply for other H2R species isoforms. More-
over, H2Rs are known to be constitutively active (Alewijnse et
al., 1998), but the degree to which constitutive activity varies
among several species isoforms remains elusive. To generate
an expanded pharmacological profile of H2R species isoforms,
in the present report, we compare human, guinea pig, rat,
and canine H2Rs.
Sf9 cell membranes expressing H2R-GsS fusion proteins
were used to measure steady-state GTPase activity. For this
purpose, we studied several classes of H2R ligands (Fig. 2).
HA (1) and related small H2R agonists DIM (2), AMT (3), and
BET (4) similarly interact with the binding site of H2R. The
amino group of HA forms an ionic interaction with Asp-
98(3.32) in TM3, and the imidazolyl ring presumably inter-
acts with Tyr-182(5.38) and Asp-186(5.42) in TM5 (Fig. 1).
The guanidine-type H2R agonists impromidine (8, IMP),
arpromidine (9, ARP), and BU-E-43 (10), as well as the
NG-acylated derivatives 11 to 16 share a common N-[3-(1H-
imidazol-4-yl)propyl)]guanidine moiety that mimics binding
of HA and thus is crucial for agonistic activity (Dove et al.,
2004). The 2-(5-methylimidazol-4-ylmethylthio)ethyl moiety
of IMP and the 3-(4-fluorophenyl)-3-(2-pyridyl)propyl group
of ARP are supposed to interact with a pocket formed by
multiple residues in TM3, -6, and -7 (Kelley et al., 2001). The
variable side chains of the ARP derivatives 10 to 16 consist of
diverse mono- or diarylalkyl groups with different chain
lengths between the aromatic ring system and the guanidine
group. In compound 16 (Xie et al., 2006b), the aryl ring is
replaced by a cyclohexyl moiety. Compound 13 is the pure
(R)-enantiomer (eutomer). 2-Benzylhistamine (5) and supra-
histaprodifen (6) represent H1R agonists with partial H2R
agonism (Seifert et al., 2003). Burimamide (7) and metiamide
(22) are neutral H2R antagonists, whereas cimetidine (17,
CIM), ranitidine (18, RAN), famotidine (19, FAM), aminopo-
tentidine (20, APT), and iodoaminopotentidine (21, IAPT) act
as inverse agonists (Hill et al., 1997; Dove et al., 2004).
Previous studies showed that the determination of adeny-
lyl cyclase (AC) activity in Sf9 cell membranes is a very
sensitive system to elucidate differences in the constitutive
activities of GPCRs (Seifert et al., 1998b). Therefore, we also
assessed AC activity in membranes expressing nonfused
H2Rs (coupling to endogenous Gs-like G proteins), in mem-
branes coexpressing H2R and mammalian GsS, and in mem-
branes expressing H2R-GsS fusion proteins.
Materials and Methods
Materials. The cDNA for the rH2R was kindly provided by Dr. R.
Leurs (Leiden/Amsterdam Center for Drug Research, Department of
Medicinal Chemistry, Vrije Universiteit Amsterdam, Amsterdam,
The Netherlands) (Ruat et al., 1991). The cDNA for the cH2R was
Fig. 1. Comparison of the amino acid sequences of hH2R, gpH2R, rH2R, and cH2R. The amino acid sequences of hH2R, gpH2R, rH2R, and cH2R are
given in the one-letter code. Dots in the sequences of gpH2R, rH2R, and cH2R indicate identity with hH2R. Amino acids shown in white with black
shading represent the interaction sites of HA with the H2R (Gantz et al., 1992; Nederkoorn et al., 1996). The most conserved residues (X.50 with X
being the number of the TM domain, according to the Ballesteros/Weinstein nomenclature) in each TM domain are indicated in gray shading. Amino
acids shown in regular font in the sequences of gpH2R, rH2R, and cH2R represent conservative exchanges. Amino acids shown in bold in the sequences
of gpH2R, rH2R, and cH2R represent nonconservative exchanges. N-term, extracellular N-terminal domain of H2Rs; C-term, intracellular C-terminal
domain of H2Rs; i1, i2, and i3, first, second, and third intracellular loops; e1, e2, e3, first, second, and third extracellular loops, respectively.
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kindly provided by Dr. I. Gantz (University of Michigan, Medical
School and Ann Arbor VA Medical Center, Ann Arbor, MI) (Gantz et
al., 1991b). The generation of the baculoviruses encoding hH2R,
gpH2R, hH2R-GsS, and gpH2R-GsS was described previously
(Kelley et al., 2001; Houston et al., 2002). The baculoviruses encod-
ing GsS were kindly provided by Drs. R. Sunahara and A. G. Gilman
(Department of Pharmacology, University of Southwestern Medical
Center, Dallas, TX). The generation of pGEM-3Z-SF-1AR-GsS and
pVL1392-SF-1AR-GsS was described previously (Wenzel-Seifert et
al., 2002). Compounds 11 through 15 (Ghorai, 2005; Xie et al., 2006a)
and compound 16 (Xie et al., 2006b) were prepared as described
previously (Ghorai, 2005). The preparation of IMP, ARP, BU-E-43,
APT, and IAPT was described previously (Dove et al., 2004). Supra-
histaprodifen and 2-benzylhistamine were synthesized as described
previously (Elz et al., 2000; Seifert et al., 2003). The structures of
compounds were confirmed by analysis (C, H, N), 1H NMR, and mass
spectrometry. Purity of compounds was 98% as determined by
high-performance liquid chromatography or capillary electrophore-
sis. The anti-FLAG Ig (M1 monoclonal antibody) was from Sigma-
Aldrich (St. Louis, MO). The anti-Gs Ig (C-terminal) was from
Santa Cruz Biotechnology (Santa Cruz, CA), and the anti-His6 Ig
was from Clonetech (Mountain View, CA). [-32P]GTP (6000 Ci/
mmol), [-32P]ATP (800 Ci/mmol), and [3H]dihydroalprenolol (85–90
Ci/mmol) were from PerkinElmer Life and Analytical Sciences (Bos-
ton, MA). All unlabeled nucleotides were from Roche Diagnostics
(Indianapolis, IN). HA, BET, CIM, RAN, and FAM were from Sigma-
Aldrich. AMT was from Tocris Cookson Inc. (Ballwin, MO). DIM was
from Sigma/RBI (Natick, MA). Burimamide and metiamide were
from Dr. W. Schunack (Free University of Berlin, Berlin, Germany).
All restriction enzymes, T4 DNA ligase, and calf intestinal phospha-
tase were from New England Biolabs (Beverly, MA). Cloned Pfu
DNA polymerase was from Stratagene (La Jolla, CA).
Construction of the cDNAs for rH2R and rH2R-GsS. The
cDNAs encoding for the proteins were generated by sequential over-
lap-extension PCRs. With pGEM-3Z-SF-gpH2R-GsS as template,
PCR 1A was used to amplify a DNA fragment consisting of the
cleavable signal peptide from influenza hemagglutinin (S), the FLAG
epitope (F) recognized by the M1 monoclonal antibody, and the start
codon of the rH2R. The sense primer annealed with 18 bp of
pGEM-3Z before the 5 end of SF. The antisense primer annealed
with 15 bp of the 3 end of SF and with ATG. In PCR 1B, the cDNA
encoding the rH2R followed by a hexahistidine tag in 3 position was
generated. The hexahistidine tag was included to allow future puri-
fication and to provide additional protection against proteolysis
(Seifert et al., 1998a). The sense primer consisted of 15 bp of the 3
end of SF and the first 22 bp of the 5 end of the rH2R. The antisense
primer consisted of 18 bp of the C terminus of the rH2R, the hexa-
histidine tag, the stop codon, and an XbaI site. The cDNA for the
rH2R was extracted from pcDNA-rH2R after restriction digestion
with HindIII and BglII and was used as template. In PCR 2, the
products of PCR 1A and PCR 1B annealed in the region encoding SF
and ATG. Here, the sense primer of PCR 1A and the antisense
primer of PCR 1B were used. In that way, a fragment encoding SF,
the rH2R, the hexahistidine tag, the stop codon, and an XbaI site was
Fig. 2. Structures of H2R agonists, partial agonists, and antagonists. 1 to 4, small H2R agonists; 5 and 6, H1R agonists with partial agonism at the
H2R; 8 to 10, guanidine-type H2R agonists; 11 to 16, N
G-acylated N-[3-(1H-imidazol-4-yl)propyl]guanidines with agonistic H2R activity; 7 and 17 to 22,
H2R antagonists.
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obtained. This fragment was digested with SacI and XbaI and cloned
into pGEM-3Z-SF-hH2R digested with SacI and XbaI to yield pGEM-
3Z-SF-rH2R. pGEM-3Z-SF-rH2R was digested with SacI and XbaI
and cloned into the baculovirus transfer vector pVL1392-SF-hH2R
digested with SacI and XbaI. With pGEM-3Z-SF-rH2R as template,
the sense primer of PCR 1A, and an antisense primer encoding six
histidines, in PCR 3A a fragment encoding SF, the cDNA for the
rH2R, and the hexahistidine tag was generated. In PCR 3B, a frag-
ment encoding the hexahistidine tag, the cDNA of GsS, the stop
codon, and an XbaI site was generated. Here, the sense primer
annealed with the hexahistidine tag and the start codon of GsS, and
the antisense primer annealed with the cDNA encoding the five
C-terminal amino acids of GsS, the stop codon, and an XbaI site.
pGEM-3Z-SF-gpH2R-GsS was used as template. In PCR 4, the prod-
ucts of PCRs 3A and 3B annealed in the hexahistidine region, and
the sense primer of PCR 1A and the antisense primer of PCR 3B
were used. In that way, the complete cDNA for the rH2R-GsS fusion
protein, consisting of SF, the cDNA for the rH2R, the hexahistidine
tag, and the cDNA of GsS was amplified. The product of PCR 4 was
digested with SacI and BglII and cloned into pGEM-3Z-SF-1AR-
GsS digested with SacI and BglII. In addition, the PCR 4 product
was digested with SacI and BglII and directly cloned into pVL1392-
SF-1AR-GsS that was digested with SacI and BglII and treated
with calf intestinal phosphatase to yield the baculovirus transfer
vector pVL1392-SF-rH2R-GsS.
Construction of the cDNAs for cH2R and cH2R-GsS. The
strategy for the generation of the cDNAs for the epitope-tagged cH2R
and cH2R-GsS was analogous to the strategy for the generation of
the cDNAs for rH2R and rH2R-GsS. With pGEM-3Z-SF-gpH2R-GsS
as template, in PCR 1A the SF region and the start codon of the cH2R
were amplified. The sense primer annealed with 18 bp of pGEM-3Z
before the 5 end of SF, and the antisense primer annealed with 15
bp of the 3 end of SF and with ATG. In PCR 1B, the cDNA encoding
the sequence for the cH2R followed by the hexahistidine tag in 3
position was generated. The sense primer consisted of 15 bp of the 3
end of SF and the first 21 bp of the 5 end of cH2R. The antisense
primer consisted of 18 bp of the C terminus of the cH2R, the hexa-
histidine tag, the stop codon, and an XbaI site. The cDNA for the
cH2R was extracted from CMVneo-cH2R after digestion with BglII
and was used as template. In PCR 2, the products of PCR 1A and
PCR 1B annealed in the region encoding SF and ATG. Here, the
sense primer of PCR 1A and the antisense primer of PCR 1B were
used. In that way, a fragment encoding SF, the cH2R, the hexahis-
tidine tag, the stop codon, and an XbaI site was obtained. This
fragment was digested with SacI and XbaI and cloned into pGEM-
3Z-SF-hH2R digested with SacI and XbaI to yield pGEM-3Z-SF-
cH2R. pGEM-3Z-SF-cH2R was digested with SacI and XbaI and
cloned into the baculovirus transfer vector pVL1392-SF-hH2R di-
gested with SacI and XbaI. PCR 3 was used to generate a fragment
encoding the C terminus of the cH2R, the hexahistidine tag, and
GsS. The sense primer encoded the last 10 amino acids of the C
terminus of the cH2R, the hexahistidine tag, and the start codon of
GsS, and the antisense primer encoded the five C-terminal amino
acids of GsS, the stop codon, and an XbaI site. Here, pGEM-3Z-SF-
hH2R-GsS was used as template. This fragment was digested with
XhoI and XbaI and cloned into pGEM-3Z-SF-cH2R digested with
XhoI and XbaI to yield pGEM-3Z-SF-cH2R-GsS. pGEM-3Z-SF-cH2R-
GsS was digested with SacI and BglII and cloned into pVL1392-
SF-1AR-GsS that was digested with SacI and BglII and treated
with calf intestinal phosphatase to yield the baculovirus transfer
vector pVL1392-SF-cH2R-GsS.
Generation of Recombinant Baculoviruses, Cell Culture,
and Membrane Preparation. Recombinant baculoviruses encod-
ing rH2R, cH2R, rH2R-GsS, and cH2R-GsS were generated in Sf9
cells using the BaculoGOLD transfection kit (BD Biosciences PharM-
ingen, San Diego, CA) according to the manufacturer’s instructions.
After initial transfection, high-titer virus stocks were generated by
two sequential virus amplifications. Sf9 cells were cultured in 250-ml
disposable Erlenmeyer flasks at 28°C under rotation at 125 rpm in
SF 900 II medium (Invitrogen, Carlsbad, CA) supplemented with 5%
(v/v) fetal calf serum (Cambrex Bio Science Walkersville Inc., Walk-
ersville, MD) and 0.1 mg/ml gentamicin (Cambrex Bio Science Walk-
ersville Inc.). Cells were maintained at a density of 0.5 to 6.0  106
cells/ml. For infection, cells were sedimented by centrifugation and
suspended in fresh medium. Cells were seeded at 3.0  106 cells/ml
and infected with a 1:100 dilution of high-titer baculovirus stocks
encoding H2Rs, GsS, and H2R-GsS fusion proteins. Cells were cul-
tured for 48 h before membrane preparation. Sf9 membranes were
prepared as described previously (Seifert et al., 1998a), using 1 mM
EDTA, 0.2 mM phenylmethylsulfonyl fluoride, 10 g/ml benzami-
dine, and 10 g/ml leupeptin as protease inhibitors. Membranes
were suspended in binding buffer (12.5 mMMgCl2, 1 mM EDTA, and
75 mM Tris-HCl, pH 7.4) and stored at 80°C until use.
SDS-PAGE and Immunoblot Analysis. Membrane proteins
were separated on SDS polyacrylamide gels containing 12% (w/v)
acrylamide. Proteins were then transferred onto Immobilon-P trans-
fer membranes (Millipore Corporation, Bedford, MA). Membranes
were reacted with M1 antibody, anti-Gs Ig, or anti-His6 Ig (1:1000
each). Immunoreactive bands were visualized by enhanced chemolu-
minescence (Pierce Chemical, Rockford, IL) using sheep anti-mouse
IgG (M1 and anti-His6 Ig) and donkey anti-rabbit IgG (anti-Gs Ig),
respectively, coupled to peroxidase.
Steady-State GTPase Activity Assay. Membranes were
thawed, sedimented, and resuspended in 10 mM Tris-HCl, pH 7.4.
Assay tubes contained Sf9 membranes expressing H2R-GsS fusion
proteins (10 g of protein/tube), 1.0 mM MgCl2, 0.1 mM EDTA, 0.1
mM ATP, 100 nM GTP, 0.1 mM adenylyl imidodiphosphate, 5 mM
creatine phosphate, 40 g of creatine kinase, and 0.2% (w/v) bovine
serum albumin in 50 mM Tris-HCl, pH 7.4, and H2R ligands at
various concentrations. Reaction mixtures (80 l) were incubated for
2 min at 25°C before the addition of 20 l of [-32P]GTP (0.1 Ci/
tube). All stock and work dilutions of [-32P]GTP were prepared in 20
mM Tris-HCl, pH 7.4. Reactions were conducted for 20 min at 25°C.
Preliminary studies under basal conditions and with HA, IMP, and
ARP showed that under these conditions, GTP hydrolysis was linear.
Reactions were terminated by the addition of 900 l of slurry con-
sisting of 5% (w/v) activated charcoal and 50 mM NaH2PO4, pH 2.0.
Charcoal absorbs nucleotides but not Pi. Charcoal-quenched reaction
mixtures were centrifuged for 7 min at room temperature at 15,000g.
Six hundred microliters of the supernatant fluid of reaction mixtures
was removed, and 32Pi was determined by liquid scintillation count-
ing. Enzyme activities were corrected for spontaneous degradation of
[-32P]GTP. Spontaneous [-32P]GTP degradation was determined in
tubes containing all of the above-described components plus a very
high concentration of unlabeled GTP (1 mM) that, by competition
with [-32P]GTP, prevents [-32P]GTP hydrolysis by enzymatic ac-
tivities present in Sf9 membranes. Spontaneous [-32P]GTP degra-
dation was 1% of the total amount of radioactivity added using 20
mM Tris-HCl, pH 7.4, as solvent for [-32P]GTP. The experimental
conditions chosen ensured that not more than 10% of the total
amount of [-32P]GTP added was converted to 32Pi.
AC Activity Assay. AC activity in Sf9 membranes was deter-
mined as described previously (Houston et al., 2002). In brief, mem-
branes were thawed and sedimented by a 15-min centrifugation at
4°C and 15,000g to remove residual endogenous guanine nucleotides
as far as possible, and they were subsequently resuspended in bind-
ing buffer. Tubes contained Sf9 membranes expressing H2Rs (100 g
of protein/tube), H2Rs coexpressed with mammalian GsS (50 g of
protein/tube), or H2R-GsS fusion proteins (20 g of protein/tube),
additionally 5 mM MgCl2, 0.4 mM EDTA, and 30 mM Tris-HCl, pH
7.4. Assay tubes containing membranes and various additions in a
total volume of 30 l were incubated for 3 min at 37°C before starting
reactions by the addition of 20 l of reaction mixture containing
(final) [-32P]ATP (0.3 Ci/tube) plus 40 M unlabeled ATP, 2.7 mM
mono(cyclohexyl)ammonium phosphoenolpyruvate, 0.125 IU of pyru-
vate kinase, 1 IU of myokinase, and 0.1 mM cAMP. Reactions were
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conducted for 20 min at 37°C. Reactions were terminated by the
addition of 20 l of 2.2 N HCl. Denatured protein was sedimented by
a 3-min centrifugation at 25°C and 15,000g. Sixty-five microliters of
the supernatant fluid was applied onto disposable columns filled
with 1.3 g of neutral alumina (Sigma A-1522, super I, WN-6).
[32P]cAMP was separated from [-32P]ATP by elution of [32P]cAMP
with 4 ml of 0.1 M ammonium acetate, pH 7.0. Recovery of
[32P]cAMP was 80%. Blank values were routinely 0.01% of the
total amount of [-32P]ATP added. [32P]cAMP was determined by
liquid scintillation counting. The experimental conditions chosen
ensured that not more than 1 to 3% of the total amount of [-32P]ATP
added was converted to [32P]cAMP.
Miscellaneous. Protein concentrations were determined using
the DC protein assay kit (Bio-Rad, Hercules, CA). [3H]Dihydroalpre-
nolol saturation binding was performed as described previously
(Seifert et al., 1998a). All analyses of experimental data were per-
formed with the Prism 4 program (GraphPad Software Inc., San
Diego, CA). KB values were calculated using the Cheng and Prusoff
equation (1973) equation. Expression levels of recombinant proteins
were determined using the Bio-Rad GS-710 calibrated imaging
densitometer and the software tool Quantity One, version 4.0.3
(Bio-Rad).
Results
Immunological Detection of Recombinant Proteins
in Sf9 Cell Membranes. The predicted molecular mass of
the H2R is 33 kDa (Gantz et al., 1991a,b; Fukushima et al.,
1997). H2R species isoforms presumably exhibit similar gly-
cosylation patterns, because the putative N-glycosylation
sites for the H2R, Asn-4, and Asn-162 are fully conserved
within their sequences (Fig. 1) (Fukushima et al., 1995).
However, only rH2R and hH2R migrated as the expected
bands for monomeric GPCRs (Fig. 3, A and B). Both bands
occur as doublets, representing different glycosylation forms
(Houston et al., 2002). Additional bands were detected at70
kDa, presumably representing receptor dimers. A similar
pattern of immunoreactive bands was previously observed
for the hH2R (Houston et al., 2002). In contrast, both cH2R
and gpH2R displayed strong doublet bands at 60 kDa that
coincide with the expected bands of differentially glycosy-
lated H2R dimers, whereas the bands for monomers were
absent. Additional bands were detected at 150 kDa and
above 250 kDa, possibly corresponding to H2R tetramers and
higher oligomers, respectively. Dimerization and oligomer-
ization of the cH2R has been described previously (Fuku-
shima et al., 1997), but in those experiments, also receptor
monomers were detected. Hence, gpH2R and cH2R possibly
migrated atypically in SDS-PAGE, i.e., the bands at 60 and
150 kDa could correspond to monomers and dimers, respec-
tively, and not to dimers and tetramers. With the anti-His6
Ig, in membranes expressing cH2R, an additional doublet
band at 23 kDa was detected, and in rH2R- and hH2R
membranes, an 27-kDa band was present. However, no
such bands were detected in gpH2R membranes. The 23–
27-kDa bands may represent differentially and atypically
migrating H2R monomers not recognized by the M1 antibody
because of a lack of epitope exposure. By analogy to formyl
peptide receptors (Wenzel-Seifert and Seifert, 2003) differ-
ences in the C termini of H2R species isoforms may constitute
the molecular basis for the species-selective migration pat-
tern. Thus, H2R species isoforms are well expressed in Sf9
membranes, but due to their widely different migration, it is
impossible to precisely assess their expression levels using
2AR-membranes calibrated with [
3H]dihydroalprenolol sat-
uration binding as standard (Kelley et al., 2001).
H2R-GsS fusion proteins of canine, rat, guinea pig, and
human occurred as strong bands at 80 kDa (Fig. 3C). Be-
cause GsS has an apparent molecular mass of 45 kDa,
these bands correspond to H2R-GsS monomers. Weaker
Fig. 3. Immunological detection and
analysis of the expression of recombi-
nant proteins in Sf9 cells. Sf9 mem-
branes expressing various proteins
were prepared, separated by SDS-
PAGE on gels containing 12% (w/v)
acrylamide, transferred onto Immo-
bilon-P membranes, and probed with
the respective Ig indicated on top of
each panel. In each lane, 10 g of
membrane protein was loaded onto
the gel, unless otherwise indicated be-
low membranes. Exceptionally, 40 g
of a membrane expressing gpH2R-
GsS were loaded onto the gels in C
and D. Numbers on the left of mem-
branes designate masses of marker
proteins in kilodaltons. In A and C, 1,
2, 5, and 10 g of protein of Sf9
membranes expressing the 2AR at
7.5 pmol mg1 (as determined by
[3H]DHA saturation binding) were
used as standard to assess the expres-
sion levels of H2R species isoforms. In
D, membranes expressing H2R-GsS
fusion proteins and membranes coex-
pressing H2R species and mammalian
GsS were loaded onto the gel.
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bands were detected at 110 kDa, most probably represent-
ing differently glycosylated fusion proteins. With all species,
additional bands at 250 kDa were detected, presumably
representing H2R-GsS dimers or oligomers. cH2R-GsS was
expressed at 5 pmol mg1, rH2R-GsS at 4 pmol mg
1,
gpH2R-GsS at 1 pmol mg
1, and hH2R-GsS at 3 pmol
mg1 using 2AR-membranes as standard. To account for the
decreased expression level of gpH2R-GsS, in this case the
amount of protein applied to the gel was adjusted to 40 g.
Probing membranes expressing H2R-GsS species with the
anti-Gs Ig yielded 80- and 250-kDa bands (Fig. 3D),
which are consistent with those bands observed with the
anti-FLAG Ig. Additional bands occurred at 45 kDa, repre-
senting atypically migrating or partially degraded fusion pro-
teins. In all membranes coexpressing H2R species and GsS,
the expected bands for GsS monomers were detected at 45
kDa. The expression levels of GsS in membranes coexpress-
ing H2R and GsS were estimated using the 80-kDa peak
intensities of H2R-GsS species as standard and were 2
pmol mg1 in membranes coexpressing cH2R and GsS, 2
pmol mg1 in membranes coexpressing rH2R and GsS, 1
pmol mg1 in membranes coexpressing gpH2R and GsS, and
1 pmol mg1 in membranes coexpressing hH2R and GsS.
Efficacies and Potencies of Agonists at H2R-GsS
Species Isoforms Derived from the GTPase Assay. Ef-
ficacies and potencies of compounds 1 to 22 at H2R-GsS
fusion proteins of human, guinea pig, rat, and canine are
summarized in Table 1. The small H2R agonists acted as full
(1-3) or as nearly full (4) agonists at the four receptors with
approximately similar efficacies. HA (1) and DIM (2) were
equipotent at human, guinea pig, and rat H2R-GsS, they but
showed lower EC50 values at cH2R-GsS. AMT (3) was
slightly more potent at cH2R-GsS than at hH2R-GsS and
gpH2R-GsS. At rH2R-GsS, the potency of AMT (3) was fur-
ther decreased. BET (4) acted with increased potencies at
gpH2R-GsS and cH2R-GsS, compared with hH2R-GsS and
rH2R-GsS. In agreement with previous studies (Kelley et al.,
2001; Xie et al., 2006a,b), N-[3-(1H-imidazol-4-yl)propyl]gua-
nidines (8-10) and their NG-acylated analogs (11-16) were
more potent and more efficacious at gpH2R-GsS than at
hH2R-GsS (Table 1). At gpH2R-GsS, UR-PG222A (13) was
more efficacious than HA (1). At hH2R-GsS and rH2R-GsS,
the compounds exhibited similar efficacies and potencies.
Only UR-PG214 (11) was slightly more potent at rH2R-GsS
than at hH2R-GsS. Apart from ARP (9) and its N
G-acylated
analog UR-PG136 (15) that acted with similar efficacies at
cH2R-GsS and hH2R-GsS, compounds 8 to 16 were more
efficacious at cH2R-GsS than at hH2R-GsS. Compounds 8 to
16 were also more potent at cH2R-GsS than at hH2R-GsS.
An exception of this rule was UR-PG123 (14) that exhibited
the largest efficacy increase (4-fold) but was somewhat less
potent at cH2R-GsS than at hH2R-GsS. In summary, small
H2R agonists 1 to 4 acted with similar efficacies at all H2R-
GsS species isoforms investigated, but they were more po-
tent at cH2R-GsS compared with hH2R-GsS, gpH2R-GsS,
and rH2R-GsS. Guanidines and N
G-acylated guanidines 8 to
16 acted with increased efficacies and potencies at gpH2R-
GsS and cH2R-GsS compared with hH2R-GsS, whereas no
selectivity was observed between rH2R-GsS and hH2R-GsS.
Compounds 5 and 6 are representatives of H1R agonists
with partial H2R agonism (Seifert et al., 2003). Both com-
pounds were less efficacious at gpH2R-GsS than at hH2R-
GsS and similarly efficacious at rH2R-GsS and hH2R-GsS
(Table 1). In the GTPase assay at H2R-GsS fusion proteins,
burimamide (7) was a weak partial agonist with similar
efficacies at human, guinea pig, and rat species. Strikingly,
compounds 5, 6, and 7 acted with significantly increased
efficacies at cH2R-GsS compared with hH2R-GsS. Apart
from 2-benzylhistamine (5) with2-fold increased potency at
gpH2R-GsS, the potencies of 5 to 7 did not significantly differ
between the species investigated. Taken together, partial
H2R agonists were considerably more efficacious at cH2R-
GsS than at human, guinea pig, and rat H2R-GsS.
Potencies and Inverse Agonist Efficacies of Antago-
nists at H2R-GsS Species Isoforms Derived from the
GTPase Assay. KB values and inverse agonist efficacies of
the H2R antagonists CIM (17), RAN (18), FAM (19), APT
(20), and IAPT (21) are listed in Table 2. The compounds
decreased GTPase activities below basal values and thus
acted as inverse agonists at all four species. At hH2R-GsS
and gpH2R-GsS compounds 17 to 21 decreased the basal
GTPase signal (0%) by 10% if the maximal stimulatory
effect of 100 M HA was set to 100%. At rH2R-GsS the
inverse agonist efficacies of 17 to 21 were somewhat smaller.
At cH2R-GsS all compounds except CIM (17) showed a sig-
nificantly higher reduction of the basal GTPase activity by
20%. The KB values of 17 to 21 were similar at hH2R-GsS
and gpH2R-GsS. At rH2R-GsS, 17 to 19 were less potent,
and 20 and 21 were similarly potent compared with hH2R-
GsS. By contrast, all compounds except FAM (19) were less
potent at cH2R-GsS than at hH2R-GsS. Taken together,
most of the H2R antagonists studied displayed increased
inverse agonist efficacies and decreased potencies at cH2R-
GsS compared with hH2R-GsS.
Constitutive Activities of hH2R-GsS, gpH2R-GsS,
rH2R-GsS, and cH2R-GsS in the GTPase Assay. As was
reported for a constitutively activated mutant of the 2AR
(Samama et al., 1993), the following major hallmarks distin-
guish constitutively active GPCRs from not (quiescent) or
less constitutively active GPCRs. First, the efficacies of par-
tial agonists are increased at the more constitutively active
receptor. To uncover differences in the constitutive activities
among H2R-GsS species, efficacies of partial and full ago-
nists 1 to 16 and inverse agonist efficacies of antagonists 17
to 21 were compared at hH2R-GsS with gpH2R-GsS, rH2R-
GsS, and cH2R-GsS, respectively (Fig. 4, A, C, and E). Sec-
ond, constitutively active receptors exhibit an increased af-
finity for agonists but not antagonists, with the extent of
affinity increase being correlated with the efficacy of the
ligand (Lefkowitz et al., 1993). Essentially, the potencies in
the GTPase assay represent apparent affinities and can be
therefore related, as logEC50 differences between hH2R-GsS
and the other H2R species isoforms, to the corresponding
efficacies at hH2R-GsS (Fig. 4, B, D, and F). Finally, at
receptors with increased constitutive activity inverse ago-
nists have an elevated inhibitory effect on GTP hydrolysis
(Seifert et al., 1998b).
Similar inverse agonist efficacies of antagonists 17 to 21
and the absence of selectivity in the efficacies of partial
agonists 5 to 7 and 14 indicate equal magnitudes of consti-
tutive activities for gpH2R-GsS and hH2R-GsS (Fig. 4A). As
Fig. 4B illustrates, a poor but significant correlation (r2 
0.27; p  0.016) was observed between the log (potency ratio)
of these species and the efficacies of compounds 1 to 21 at
988 Preuss et al.
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hH2R-GsS. However, this correlation was determined by
ligand-specific interactions, namely, the high potencies of
guanidines (8 to 10) and NG-acylguanidines (11 to 16) at
gpH2R-GsS (Kelley et al., 2001; Xie et al., 2006a,b), and
disappeared if only compounds 1 to 7 and 17 to 21 were
considered (r2 0.04; p 0.527). The efficacies of compounds
1 to 21 at rH2R-GsS and hH2R-GsS were almost identical
(Fig. 4C). Moreover, no correlation between the log (potency
ratio) and the efficacies at hH2R-GsS was evident (r
2  0.16;
p  0.077) (Fig. 4D). Thus, in the steady-state GTPase assay,
rH2R-GsS and hH2R-GsS exhibited similar levels of consti-
tutive activities. By contrast, cH2R-GsS showed the hall-
marks of a GPCR with increased constitutive activity com-
pared with hH2R-GsS. Specifically, partial agonists 5 to 7
and 14 were considerably more efficacious at cH2R-GsS and
the inverse agonist efficacies of antagonists 18 to 21 were
increased compared with hH2R-GsS (Fig. 4E). A highly sig-
nificant correlation between the log (potency ratio) and the
efficacies of compounds 1 to 21 at hH2R-GsS was determined
(r2  0.77; p  0.0001; Fig. 4F). It is noteworthy that this
correlation was independent of distinct interactions of gua-
nidines and NG-acylguanidines with cH2R-GsS as omitting
compounds 8 to 16 did not change the fit (r2  0.75; p 
0.0003).
Ambiguous Response of Metiamide (22) in the
GTPase Assay. At hH2R-GsS, metiamide (22) decreased
the basal GTPase signal by 8  1% and thus acted as weak
inverse agonist (Table 1; Fig. 5). At gpH2R-GsS and rH2R-
GsS, metiamide inhibited the basal GTPase signals by 6  1
and 4  1%, respectively, and was 2-fold more potent than
at hH2R-GsS. Intriguingly, at cH2R-GsS metiamide did not
act as an inverse agonist but rather as a very weak partial
agonist (efficacy of 6  1%). This is in marked contrast to the
results of antagonists 18 to 21 reducing the basal GTPase
signal at cH2R-GsS (increased constitutive activity) more
effectively than at the other less constitutively active species.
Furthermore, the potency of 22 was lowered by approxi-
mately 15-fold compared with hH2R-GsS and not increased
as would have been expected for a partial agonist (Samama
et al., 1993). Attempts to detect changes in AC activity upon
stimulation with metiamide in membranes coexpressing
cH2R and GsS failed due to the much lower sensitivity of this
system compared with the GTPase activity assay using fu-
sion proteins (data not shown).
Regulation of AC Activities in Membranes Express-
ing Fused and Nonfused H2R Species Isoforms. AC ac-
tivity was measured in Sf9 cell membranes expressing H2Rs
(coupling to endogenous Gs-like G proteins), in membranes
coexpressing H2R and mammalian GsS, and in membranes
expressing H2R-GsS fusion proteins. Basal AC activities
were similar in membranes expressing hH2R, gpH2R, and
rH2R (Table 3) and 2-fold higher in the case of the cH2R.
GTP (10 M) by itself increased AC activities at all four H2R
species by 2-fold above the basal level. HA (1) further
increased, and IAPT (21) inhibited this GTP-dependent sig-
nal increase, indicative for constitutive activity of all four
H2R species isoforms in Sf9 membranes (Fig. 6, A–D). These
observations are in agreement with previous studies at the
2AR (Seifert et al., 1998a). The stimulatory effects of GTP,
as determined by relating the effects of GTP (10 M) to the
effects of HA (100 M) plus GTP (10 M), were largest at
cH2R and rH2R, compared with hH2R and gpH2R. Both the
high basal AC activity and the strong stimulation with GTP
indicate an elevated level of constitutive activity in mem-
branes expressing the cH2R relative to membranes express-
ing hH2R, gpH2R, and rH2R. It is noteworthy that the con-
stitutive activity of rH2R seemed to be slightly increased
compared with hH2R and gpH2R.
The GPCR/G protein stoichiometry affects the magnitude
of response (Kenakin, 2001). In H2R membranes coexpress-
ing mammalian GsS, 5- to 18-fold increased basal levels of
AC activity were measured relative to membranes express-
ing H2R alone (Table 3). Basal AC activities were 6-fold
higher at cH2R plus GsS and 2-fold higher at rH2R plus
GsS, respectively, compared with hH2R plus GsS. With
gpH2R plus GsS, the basal AC activity was somewhat lower
than with hH2R plus GsS. As was observed in membranes
expressing H2R alone, the highest stimulatory effects of GTP
in the coexpression system were observed with cH2R and
rH2R compared with gpH2R and hH2R. The inverse agonist
IAPT (10 M) decreased the GTP-dependent increases of AC
activity at all species isoforms (Fig. 6, E–H), but even
strongly reduced basal AC activities at the lowest concentra-
tions of added GTP. These effects were probably due to traces
of GDP being converted to GTP by the action of nucleoside
diphosphate kinase and were most prominent in membranes
expressing cH2R plus GsS (69% reduction below basal) and
rH2R plus GsS (59% reduction), compared with hH2R plus
TABLE 2
Potencies and inverse agonist efficacies of antagonists at H2R-GsS species isoforms in the GTPase assay
Steady-state GTPase activity in Sf9 membranes expressing hH2R-GsS, gpH2R-GsS, rH2R-GsS, and cH2R-GsS was determined as described underMaterials and Methods.
Reaction mixtures contained Sf9 membranes expressing fusion proteins, 1 M HA as agonist and antagonists at concentrations from 1 nM to 100 M as appropriate to
generate saturated competition curves. Competition curves were analyzed by nonlinear regression. To determine the inverse agonist efficacies (Inv. Ago. Eff.), the effects of
antagonists at fixed concentrations (10 M of 18–21; 100 M of 17) on basal GTPase activity were assessed and referred to the stimulatory effect of 100 MHA (1.00). Data
shown are the means  S.D. of three experiments performed in duplicates. KB values and inverse agonist efficacies, respectively, of antagonists at hH2R-GsS were compared
with the corresponding parameters at gpH2R-GsS, rH2R-GsS, and cH2R-GsS, respectively, using one-way ANOVA. The control data for hH2R-GSS and gpH2R-GSS are
identical with the control data for these constructs in Table 2 of Preuss et al. (2007).
Compound
hH2R-GsS gpH2R-GsS rH2R-GsS cH2R-GsS
KB Inv. Ago. Eff. KB
a Inv. Ago. Eff. KB
a Inv. Ago. Eff.b KB Inv. Ago. Eff.
b
nM nM nM nM
17 CIM 1700  430 0.08  0.01 1300  270 0.09  0.02 2800  340* 0.06  0.01 7500  400** 0.07  0.02
18 RAN 840  94 0.09  0.01 1000  170 0.08  0.01 2100  410** 0.06  0.01		 1500  160* 0.18  0.01		
19 FAM 48  10 0.10  0.02 38  3 0.10  0.01 91  7** 0.07  0.01	 59  1 0.22  0.01		
20 APT 180  12 0.09  0.01 260  43* 0.09  0.01 170  27 0.06  0.01	 620  49** 0.20  0.01		
21 IAPT 35  7 0.10  0.01 26  4 0.10  0.01 32  8 0.07  0.01		 83  21** 0.22  0.01		
a Comparison with the KB value at hH2R-GsS; *, p  0.05; **, p  0.01.
b Comparison with Inv. Ago. Eff. at hH2R-GsS;
	, p  0.05; 		, p  0.01.
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GsS (29% reduction) and gpH2R plus GsS (23% reduc-
tion). Taken together, among H2R species isoforms coex-
pressed with GsS, cH2R was the most constitutively active
GPCR.
Due to the efficient coupling of the signaling partners in
GPCR-Gs fusion proteins (Seifert et al., 1999), in mem-
branes expressing H2R-GsS, strongly elevated basal AC ac-
tivities were measured, compared with membranes express-
ing nonfused H2Rs coexpressing GsS (Table 3). In agreement
with the results obtained for membranes expressing non-
fused H2Rs, among the four species isoforms, cH2R-GsS and
rH2R-GsS exhibited the highest basal AC activities. As
shown in Fig. 6, K and L, GTP increased AC activity in those
membranes so effectively that HA could not produce a fur-
ther increase, reflecting exhaustion of the limiting pool of AC
molecules (Seifert at al., 1998a). At hH2R-GsS and gpH2R-
GsS, GTP induced only smaller increases, allowing HA to
further enhance AC activity. By contrast, in the absence of
added GTP, HA (100 M) yielded a reduction of basal AC
activities at all four species (Fig. 6, I–L). Very similar effects
were observed previously for the 2AR-GsS fusion protein
(Seifert et al., 1998b) and are due to dissociation of GDP from
GsS following agonist binding to the receptor without sub-
sequent binding of GTP. Because Gs-GDP is more effective in
activating AC than nucleotide-free Gs, AC activity was re-
duced below basal. Due to much less efficient coupling in
membranes coexpressing receptors and GsS (Seifert et al.,
1998a; Houston et al., 2002; Gille and Seifert, 2003), in this
case HA did not reduce basal AC activity (Fig. 6, E–H).
Similar differences in the coupling efficiencies between fu-
sion proteins and nonfused expression systems were ob-
served in terms of ternary complex formation, guanosine
5-O-(3-thio)triphosphate binding, GTP hydrolysis, and AC
activation in the presence of GTP (Seifert et al., 1998a;
Wenzel-Seifert et al., 2002; Gille and Seifert, 2003). Thus, in
membranes expressing H2R-GsS fusion proteins the appar-
ent constitutive activities were considerably higher than in
membranes expressing nonfused H2Rs. In the case of cH2R-
GsS and rH2R-GsS, saturation of AC molecules became
manifest upon agonist (HA) stimulation.
Discussion
Increased Constitutive Activity of the cH2R Com-
pared with hH2R, gpH2R, and rH2R. The use of GPCR-
Fig. 4. Efficacies and potencies of ligands 1 to 21 at hH2R-GsS in
pairwise comparison with gpH2R-GsS, rH2R-GsS, and cH2R-GsS, re-
spectively, as determined in the steady-state GTPase assay. GTPase
activity in Sf9 membranes was measured as described under Materials
and Methods. Data shown are the means taken from Tables 1 and 2. A, C,
and E, relation between the efficacies of compounds 1 to 21 at hH2R-GsS
versus gpH2R-GsS (A), rH2R-GsS (C), and cH2R-GsS (E), respectively.
The dashed line has a slope of 1.0 and represents a theoretical curve of
identical efficacies in both systems. B, D, and F, relation between log
(potency ratio) of compounds 1 to 21 at gpH2R-GsS (B), rH2R-GsS (D),
and cH2R-GsS (F), respectively, and the corresponding efficacies at
hH2R-GsS. The potency ratio is the ratio of EC50 values of full and partial
agonists (1–16) at hH2R-GsS and at gpH2R-GsS, rH2R-GsS, and cH2R-
GsS, respectively. Accordingly, the potency ratio of antagonists (17–21) is
the ratio of the corresponding KB values at hH2R-GsS and at gpH2R-GsS,
rH2R-GsS, and cH2R-GsS, respectively. The vertical dashed line inter-
sects the abscissa at 0.0 and represents a theoretical curve of identical
potencies in both systems.
Fig. 5. Effects of metiamide on GTPase activity in membranes expressing
H2R-GsS species isoforms. GTPase activity in Sf9 membranes was de-
termined as described under Materials and Methods. Reaction mixtures
contained membranes (10 g of protein/tube) expressing hH2R-GsS,
gpH2R-GsS, rH2R-GsS, and cH2R-GsS fusion proteins and metiamide at
concentrations indicated on the abscissa. Data are expressed as percent-
age change in GTPase activity induced by metiamide compared with the
GTPase activity stimulated by HA (100 M). Data shown are the
means  S.E.M. of three independent experiments performed in dupli-
cates. Data were analyzed by nonlinear regression and were best fitted to
sigmoidal concentration-response curves. The significance of the devia-
tion from zero was calculated for each mean value using t test; , p 0.05;
, p  0.01; , p  0.001.
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Gs fusion protein in combination with the determination of
GTPase activity in Sf9 cell membranes was previously shown
to be an appropriate system to quantify constitutive activity
(Seifert et al., 1998b; Seifert and Wenzel-Seifert, 2002). This
system fixes GPCR/G protein coupling and stays at a proxi-
mal level, thus avoiding potential bias caused by more down-
stream effects, such as effector activation or changes in gene
expression. Moreover, due to the defined 1:1 stoichiometry of
receptor and Gs in fusion proteins, ligand potencies and
efficacies in the steady-state GTPase assay are independent
of the expression levels, allowing for the comparison of vari-
ous membrane preparations with different expression levels
(Seifert et al., 1999; Milligan, 2000).
We comprehensively characterized the human, guinea pig,
rat, and canine H2R species isoforms in steady-state GTPase
assays in Sf9 cell membranes expressing H2R-GsS fusion
proteins. Structurally diverse H2R full and partial agonists
and antagonists unmasked considerable differences in the
constitutive activities of the receptors. Specifically, cH2R-
GsS but neither rH2R-GsS nor gpH2R-GsS displayed the
hallmarks of increased constitutive activity compared with
hH2R-GsS (Lefkowitz et al., 1993; Samama et al., 1993): 1)
increased efficacies of partial agonists, 2) increased potencies
of agonists with the extent of potency increase being corre-
lated with the efficacy, and 3) increased inverse agonist effi-
cacies and decreased potencies of antagonists.
The determination of AC activity in Sf9 cell membranes is
an alternative and sensitive method to investigate constitu-
tive activity of GPCRs (Seifert et al., 1998a). With respect to
AC, differences in the basal activity and in the magnitudes of
signal increases upon stimulation with GTP are indicators
for various levels of constitutive activity. In the AC activity
assay with membranes expressing nonfused H2R species iso-
forms either without or together with mammalian GsS, both
effects were most pronounced for canine relative to human,
guinea pig, and rat, corroborating the outstanding role of
cH2R in terms of constitutive activity.
However, our analysis of AC activity in membranes ex-
pressing H2R species isoforms also illustrates the limitations
of this system. Most importantly, the low concentration lev-
els of AC molecules constrain the maximal signal output,
thereby yielding large stimulatory effects of GTP and large
inhibitory effects of inverse agonists on AC activity. In con-
trast, the stimulatory effects of the agonist HA are small, if at
all detectable. In addition, in the case of the rH2R, basal AC
activities and the increases of AC activity upon stimulation
with GTP were moderately higher compared with the hH2R,
whereas in the GTPase activity assay rH2R-GsS and hH2R-
GsS showed similar constitutive activity. The accumulation
of rH2R in Sf9 cell membrane microdomains rich in AC mol-
ecules could be an explanation for the observed effects (Os-
trom and Insel, 2004).
It is now widely accepted that GPCR activation involves
disruption of an ionic lock between Asp(3.49) and Arg(3.50) of
the highly conserved (E/D)RY motif in TM3 and Glu(6.30) in
the cytoplasmatic extension of TM6 (Ballesteros et al., 2001;
Visiers et al., 2002). The effects of mutations in the DRY
motif on constitutive activity and structural instability of the
rat H2R were shown previously (Alewijnse et al., 2000). Asp-
115(3.49), Arg-116(3.50), and Glu-228/229(6.30) are con-
served among all H2R species isoforms. However, preceding
Glu-229(6.30) in hH2R and gpH2R and the corresponding
Glu-228(6.30) in rH2R, human, guinea pig, and rat H2Rs
exhibit an arginine (6.29), compared with a glycine (6.29), in
cH2R. Strikingly, many class A GPCRs contain a basic amino
acid at the corresponding position, and accordingly, a stabi-
lizing role of this residue in the network of ionic interactions
was proposed (Ballesteros et al., 2001). Hence, the lack of this
additional constraint in cH2R could facilitate the transition
from the inactive to the active state, resulting in the observed
enhancement in constitutive activity.
Other differences in amino acid sequences could contribute
to the differences in constitutive activity as well. Specifically,
in G649, an allelic variant of the hH2R, Asn-217 in i3, is
replaced by Asp-217. This mutant displays low basal activity
and is resistant to up-regulation upon antagonist exposure
(Fukushima et al., 2001). Intriguingly, Asn-217 is conserved
within hH2R, gpH2R, and rH2R, but it is replaced by a his-
tidine in cH2R. Moreover, major variations in the sequences
of H2R species isoforms occur in the C-terminal domain.
Because the C terminus of H2R is important for Gs protein
activation (Smit et al., 1996), the observed variations in the
constitutive activities may alternatively or additionally be
due to differences in this domain. In fact, an influence of the
TABLE 3
AC activities in Sf9 membranes expressing H2R species isoforms without or with GsS, and in Sf9 membranes expressing H2R-GsS fusion proteins
Basal AC activities and the effects of GTP and HA on AC activity were assessed. AC activity in Sf9 membranes was determined as described under Materials and Methods.
Reaction mixtures contained Sf9 membranes expressing 20 to 100 g protein/tube as appropriate and distilled water (basal), GTP (10 M), or GTP (10 M), and HA (100
M). Data shown are the means  S.D. of three to four experiments performed in triplicates. To calculate the stimulatory effect of GTP (Rel. GTP Effect), the effect of GTP
(10 M) was referred to the effect of GTP (10 M) plus HA (100 M). The control data for hH2R-GSS and gpH2R-GSS are identical with the control data for these constructs
in Table 3 of Preuss et al. (2007).
Basal, AC
Activity
10 M GTP, AC
Activity
10 M GTP 	 100 M HA, AC
Activity
Rel. GTP
Effect
pmol mg1 min1 %
hH2R 0.3  0.0 0.6  0.1 3.4  0.2 10
gpH2R 0.3  0.1 0.5  0.0 2.6  0.2 9
rH2R 0.4  0.0 0.8  0.1 3.1  0.2 15
cH2R 0.7  0.1 1.5  0.2 4.3  0.7 22
hH2R 	 GsS 2.3  0.4 6.3  0.8 11.8  0.5 42
gpH2R 	 GsS 1.5  0.3 4.4  0.5 10.8  1.5 31
rH2R 	 GsS 4.9  0.4 11.1  1.3 16.1  0.7 55
cH2R 	 GsS 12.8  1.9 24.7  4.1 31.1  3.7 65
hH2R-GsS 12.1  2.1 24.3  4.8 28.7  5.3 73
gpH2R-GsS 13.4  3.1 25.0  0.6 28.5  2.2 77
rH2R-GsS 30.5  2.6 43.5  1.7 44.4  3.0 94
cH2R-GsS 26.3  3.6 41.9  5.3 40.9  5.2 107
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C terminus on the constitutive activities of various GPCRs
was described previously (Prezeau et al., 1996; Wenzel-
Seifert and Seifert, 2003).
Ligand-Specific Interactions at H2R Species Iso-
forms. In the GTPase activity assay, N-[3-(1H-imidazol-4-
yl)propyl]guanidines and their NG-acylated analogs were
more potent and more efficacious at gpH2R-GsS than at
hH2R-GsS, which is in agreement with previous studies
(Kelley et al., 2001; Xie et al., 2006a). Because both species
isoforms exhibit similar constitutive activities, our present
data further support the concept of distinct interactions as a
rationale for this species selectivity. As was predicted by
molecular modeling studies and subsequently verified by
site-directed mutagenesis, the species selectivity of guani-
dine-type agonists is based on two distinct amino acids, Tyr-
17(1.31) in TM1 and Asp-271(7.36) in TM7 in the gpH2R,
presumably interacting via a charge assisted H-bond and
thereby stabilizing an active agonist-bound conformation
(Kelley et al., 2001). In the hH2R [Cys-17(1.31),
Ala-271(7.36)] and the rH2R [Leu-17(1.31), Gly-270(7.36)],
this interaction is impossible. Consistently, the guanidine-
type agonists were similarly efficacious and potent at rH2R-
GsS and hH2R-GsS. Both cH2R and hH2R contain Cys-
17(1.31) and Ala-271(7.36) and the differences in potencies
and efficacies of the compounds between cH2R-GsS and
hH2R-GsS were not specific to the guanidines. Thus, these
Fig. 6. Regulation of AC activities in Sf9 membranes expressing H2R species isoforms (A–D), H2R species isoforms plus GsS (E–H), or H2R-GsS fusion
proteins (I–L). AC activity in Sf9 membranes was determined as described underMaterials and Methods. Reaction mixtures contained Sf9 membranes
expressing the proteins indicated on top of each panel and GTP at concentrations indicated at the abscissa. Reaction mixtures additionally contained
H2O (f), HA (100 M) (Œ), or IAPT (10 M) (). Data shown are the means  S.E.M. of one representative experiment performed in duplicates. The
statistical analysis of AC activities is provided in Table 3. Data were analyzed by nonlinear regression and were best fitted to sigmoidal concentration-
response curves. The control data for hH2R-GSS and gpH2R-GSS are identical with the control data for these constructs in Fig. 4 of Preuss et al.
(2007).
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differences can be explained by the increased constitutive
activity of cH2R-GsS rather than by distinct ligand/GPCR
interactions.
Recently, certainNG-acylated guanidines have shown to be
more efficacious than HA at gpH2R-GsS in the GTPase assay
(Xie et al., 2006b), similar to the observations made with
UR-PG222A (13) in the present study. These effects can be
attributed to the concept of ligand-specific gpH2R conforma-
tions as well, i.e., these compounds stabilize active gpH2R
conformations that lead to more efficient interactions with
GsS than achieved with the endogenous ligand HA. By anal-
ogy, at the 2AR labeled with a fluorescent probe, the
synthetic ligand isoproterenol induced a stronger change
in fluorescence intensity than the endogenous ligand
norepinephrine (Swaminath et al., 2004).
A further example of ligand-specific interactions at H2R
species isoforms is given by metiamide, acting as a weak
partial agonist with low potency at cH2R-GsS in the GTPase
assay compared with being an inverse agonist with increased
potency at human, guinea pig, and rat H2R-GsS. Moreover,
in contrast to increased inverse agonist efficacies of antago-
nists 18 to 21 at cH2R-GsS relative to hH2R-GsS, gpH2R-
GsS, and rH2R-GsS, the inverse agonist efficacies of cime-
tidine (17), a cyanoguanidine analog of metiamide, were
similar at all four species whereas its potency was signifi-
cantly decreased at cH2R-GsS. Presumably because of the
common 2[(5-methylimidazol-4-yl)methylthio]ethyl moiety,
both metiamide and cimetidine stabilize distinct conforma-
tions in cH2R relative to the other species isoforms, thus
leading to an altered interaction with GsS, which, in the
extreme case of metiamide, causes weak partial agonism
rather than increased inverse agonism.
Conclusions
In the present study, we demonstrate that the cH2R exhib-
its increased constitutive activity compared with hH2R,
gpH2R, and rH2R. Species-specific differences in constitutive
activity were previously reported for the cholecystokinin-B/
gastrin receptor that, like the H2R, stimulates gastric H
	
production (Kopin et al., 2000). Thus, differences in consti-
tutive activities of GPCRs regulating H	 production may
reflect species-specific requirements for “basal” and peak H	
secretion in the stomach. For example, following stimulation
with HA, gastric acid secretion rates in dogs exceed those of
the human (Kararli, 1995). Moreover, by studying the H2R
antagonist metiamide, further evidence for ligand-specific
conformations of H2R species isoforms was obtained. Our
present study validates the notion that quantitative compar-
ison of species isoforms of GPCRs provides unique insights
into the molecular mechanisms of GPCR activation and li-
gand/GPCR interactions.
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